Genitourinary (Prostate, Bladder) System Archives

Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer.

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

This publication reviews the rapidly evolving management of muscle-invasive bladder cancer (MIBC), highlighting the crit...

Muscle-Invasive Bladder Cancer: A Watershed Moment.

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

The management of muscle-invasive bladder cancer (MIBC) has significantly advanced, particularly recognizing the challen...

SEOM-SOGUG clinical guideline for urothelial cancer (2025).

Post category:Genitourinary (Prostate, Bladder) System
Reading time:1 min read

This 2025 clinical guideline offers evidence-based recommendations for the diagnosis, staging, and management of bladder...

The Immunotherapy Clock Has Moved

Post category:Breast Cancer Genitourinary (Prostate, Bladder) System Head & Neck Cancers Pan Cancer Respiratory (Lung, Bronchus) System Supportive Oncology Survivorship
Reading time:3 mins read

Checkpoint inhibitors are no longer reserved for late-stage salvage. The clearest signal from recent meetings and trials is this: the greatest survival benefit may be increasingly found in neoadjuvant and perioperative settings. This…